carbohydrates - CarboHyde

2026.04.29.

Phototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin

CarboHyde, in collaboration with researchers including Salvo Sortino, Szabolcs Béni, and Milo Malanga, developed a photoresponsive β-cyclodextrin branched polymer. When exposed to visible blue light, this polymer generates nitric oxide. The researchers tested doxorubicin (DOX) in combination with the polymer. In darkness, DOX showed minimal cytotoxic effects at sub-therapeutic doses, whether used alone or combined […]

2026.04.24.

What Can We Bring Out of Cyclodextrin Polymers at CarboHyde?

CarboHyde announces a research collaboration that has yielded a new publication. The team — including Salvo Sortino, Szabolcs Béni, and Milo Malanga — developed a photoresponsive β-cyclodextrin branched polymer. When exposed to visible blue light, the polymer generates nitric oxide. The researchers tested doxorubicin (DOX) in combination with the polymer, showing that light irradiation significantly […]

2026.04.23.

Cyclodextrins in Diabetic Wound Healing

Using cyclodextrins for wound healing applications has been explored extensively, with numerous promising prototypes developed — though none have reached commercial markets until now. A breakthrough innovation by Jun Li at the National University of Singapore demonstrates a “smart multifunctional ROS-responsive supramolecular hydrogel.” This polymer is dynamically crosslinked through inclusion complexes formed between β-cyclodextrin and […]

2026.04.22.

Excited to Represent CarboHyde at Vitafoods in Barcelona!

CarboHyde’s Chief Operating Officer and Nutraceutical Innovation Head, Tamás Vargadi, will participate in the upcoming Vitafoods event in Barcelona to examine recent developments in food supplement innovations. We are particularly interested in leveraging cyclodextrins to address emerging delivery challenges — unlocking new possibilities for improved solubility, stability, and bioavailability. Vargadi will network with industry professionals, […]

2026.04.22.

Check Out How CarboHyde Cyclodextrin Polymers Worked in Delivery!

Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months. Emerging therapeutic approaches target the MAPK/ERK signalling pathway using MEK inhibitors such as trametinib and selumetinib. However, clinical progress faces obstacles including inadequate blood-brain barrier penetration and dose-limiting toxicity concerns. Researchers Noemi Bognanni, Graziella Vecchio, and […]

2026.04.21.

Another Cyclodextrin Innovation from Hungary!

RotaChrom Technologies, a global player in Centrifugal Partition Chromatography (CPC), published research on scalable enantioseparation of rac-voriconazole. Key Innovation Batch CPC baseline intensified to cyclic continuous stacked-injection CPC MDM CPC mode enables continuous injection and dual-outlet product collection MDM CPC intensification delivers approximately 25× productivity gain versus resolution Continuous CPC reduces solvent and selector use […]

Category: carbohydrates

Phototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin

What Can We Bring Out of Cyclodextrin Polymers at CarboHyde?

Cyclodextrins in Diabetic Wound Healing

Excited to Represent CarboHyde at Vitafoods in Barcelona!

Check Out How CarboHyde Cyclodextrin Polymers Worked in Delivery!

Another Cyclodextrin Innovation from Hungary!

Search

Archive

Category

Recent Post

Meet the Team!

Excited to represent CarboHyde at the DDF

Phototherapeutic β-Cyclodextrin-Branched Polymer Releasing Nitric Oxide with

Category: carbohydrates

Search

Archive

Category

Recent Post

Popular Tag